Initial bromocriptine (IB) v levodopa alone (L) and levodopa plus selegiline (LS) in early, mild Parkinson's disease at a mean 9.2 years

OutcomeComparisonsEvent rates (person years at risk)Unadjusted hazard ratios (95% CI)
‡Not significant.
MortalityIB v L58% (140) v 51% (118)1.15 (0.90 to 1.47)‡
LS v IB61% (148) v 58% (140)1.06 (0.84 to 1.34)‡
LS v L61% (148) v 51% (118)1.22 (0.95 to 1.55)‡